» Articles » PMID: 25290399

Strategies for Cell-mediated Immunotherapy of Cancer: Killing or Help?

Overview
Journal Immunol Today
Date 2014 Oct 8
PMID 25290399
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Immunotherapy I: Cyclosine gene transfer strategies.

Colombo M, Forni G Cancer Metastasis Rev. 1996; 15(3):317-28.

PMID: 9034594 DOI: 10.1007/BF00046345.


Strategies for cytokine utilisation in tumor therapy.

Di Pierro F, Cavallo F, Pericle F, Bertini S, Giovarelli M, Forni G Med Oncol Tumor Pharmacother. 1993; 10(1-2):53-9.

PMID: 8258996 DOI: 10.1007/BF02987769.


Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.

Anderson P, Bach F, Ochoa A Cancer Immunol Immunother. 1988; 27(1):82-8.

PMID: 3260824 PMC: 11038561. DOI: 10.1007/BF00205763.


Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Schild H, Von Hoegen P, Schirrmacher V Cancer Immunol Immunother. 1989; 28(1):22-8.

PMID: 2462467 PMC: 11038118. DOI: 10.1007/BF00205796.


Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cells.

Fortis C, Ferrero E, Besana C, Biffi M, Heltai S, Galli L Cancer Immunol Immunother. 1990; 32(3):161-6.

PMID: 2289209 PMC: 11038786. DOI: 10.1007/BF01771451.